Joseph Terlizzi, MD
Colon & Rectal Surgery · New York, NYNPI 1811208390
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 259 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Gilead at 51.9% of the total.
Across 259 payments — averaging $30.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$4K
- Viiv Healthcare Company$2K
- Merck$404
- Napo Pharmaceuticals Inc$372
- Kowa Pharmaceuticals America, Inc.$278
- THD America, Inc.$255
- plus $345 from 7 others
Across 4 payments — averaging $59,177 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$237K
What the payments were for
- Speaking & faculty fees$571%
- Food & beverage$7,83699%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 131 | $4,100 |
| Viiv Healthcare Company | 63 | $2,140 |
| Merck | 11 | $404 |
| Napo Pharmaceuticals Inc | 19 | $372 |
| Kowa Pharmaceuticals America, Inc. | 18 | $278 |
| THD America, Inc. | 6 | $255 |
| Hologic Sales And Service, LLC | 5 | $126 |
| Olympus America Inc. | 1 | $98 |
| Exact Sciences | 1 | $29 |
| AbbVie | 1 | $27 |
| Sandoz | 1 | $24 |
| Medtronic | 1 | $24 |
| Vioptix Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,894 in reported general payments places this provider in the 80th percentile of 177 colon & rectal surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 33 | $280 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in New York
- Sanghyun KimNew York$154K
- Mehraneh JafariNew York$50K
- Jeffrey MilsomNew York$42K
- David SchwartzbergNew York$26K
- Richard WhelanNew York$23K
- Alessandro FicheraNew York$20K
- Juliet RayNew York$17K
- Cary AaronsNew York$16K
- Debbie BakesNew York$15K
- Parul ShuklaNew York$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.